|
1
|
Xu MD, Wang Y, Weng W, Wei P, Qi P, Zhang
Q, Tan C, Ni SJ, Dong L, Yang Y, et al: A positive feedback loop of
lncRNA-PVT1 and FOXM1 facilitates gastric cancer growth and
invasion. Clin Cancer Res. 23:2071–2080. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao Y, Liu Y, Lin L, Huang Q, He W, Zhang
S, Dong S, Wen Z, Rao J, Liao W and Shi M: The lncRNA MACC1-AS1
promotes gastric cancer cell metabolic plasticity via AMPK/Lin28
mediated mRNA stability of MACC1. Mol Cancer. 17:692018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang K, Shi H, Xi H, Wu X, Cui J, Gao Y,
Liang W, Hu C, Liu Y, Li J, et al: Genome-wide lncRNA microarray
profiling identifies novel circulating lncRNAs for detection of
gastric cancer. Theranostics. 7:213–227. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xia H, Chen Q, Chen Y, Ge X, Leng W, Tang
Q, Ren M, Chen L, Yuan D, Zhang Y, et al: The lncRNA MALAT1 is a
novel biomarker for gastric cancer metastasis. Oncotarget.
7:56209–56218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lv J, Qiu M, Xia W, Liu C, Xu Y, Wang J,
Leng X, Huang S, Zhu R, Zhao M, et al: High expression of long
non-coding RNA SBF2-AS1 promotes proliferation in non-small cell
lung cancer. J Exp Clin Cancer Res. 35:752016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Y, Song X, Wang X, Hu J and Jiang L:
Silencing of LncRNA HULC enhances chemotherapy induced apoptosis in
human gastric cancer. J Med Biochem. 35:137–143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gu Y, Chen T, Li G, Yu X, Lu Y, Wang H and
Teng L: LncRNAs: Emerging biomarkers in gastric cancer. Future
Oncol. 11:2427–2441. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu H, Hu Y, Liu X, Song W, Gong P, Zhang
K, Chen Z, Zhou M, Shen X, Qian Y and Fan H: LncRNA TRERNA1
function as an enhancer of SNAI1 promotes gastric cancer metastasis
by regulating epithelial-mesenchymal transition. Mol Ther Nucleic
Acids. 8:291–299. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lan Y, Xiao X, He Z, Luo Y, Wu C, Li L and
Song X: Long noncoding RNA OCC-1 suppresses cell growth through
destabilizing HuR protein in colorectal cancer. Nucleic Acids Res.
46:5809–5821. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fu X, Li H, Liu C, Hu B, Li T and Wang Y:
Long noncoding RNA AK126698 inhibits proliferation and migration of
non-small cell lung cancer cells by targeting Frizzled-8 and
suppressing Wnt/β-catenin signaling pathway. Onco Targets Ther.
9:3815–3827. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang S, Zhong G, He W, Yu H, Huang J and
Lin T: lncRNA Up-regulated in nonmuscle invasive bladder cancer
facilitates tumor growth and acts as a negative prognostic factor
of recurrence. J Urol. 196:1270–1278. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gooding AJ, Zhang B, Jahanbani FK, Gilmore
HL, Chang JC, Valadkhan S and Schiemann WP: The lncRNA BORG drives
breast cancer metastasis and disease recurrence. Sci Rep.
7:126982017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Prensner JR, Iyer MK, Sahu A, Asangani IA,
Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, Ghadessi M, et al:
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer
and antagonizes the SWI/SNF complex. Nat Genet. 45:1392–1398. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mao Z, Li H, Du B, Cui K, Xing Y, Zhao X
and Zai S: LncRNA DANCR promotes migration and invasion through
suppression of lncRNA-LET in gastric cancer cells. Biosci Rep.
37:BSR201710702017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang FT, Chen WY, Gu ZQ, Zhuang YY, Li
CQ, Wang LY, Peng JF, Zhu Z, Luo X, Li YH, et al: The novel long
intergenic noncoding RNA UCC promotes colorectal cancer progression
by sponging miR-143. Cell Death Dis. 8:e27782017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao J, Du P, Cui P, Qin Y, Hu C, Wu J,
Zhou Z, Zhang W, Qin L and Huang G: LncRNA PVT1 promotes
angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
Oncogene. 37:4094–4109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhan HX, Wang Y, Li C, Xu JW, Zhou B, Zhu
JK, Han HF, Wang L, Wang YS and Hu SY: LincRNA-ROR promotes
invasion, metastasis and tumor growth in pancreatic cancer through
activating ZEB1 pathway. Cancer Lett. 374:261–271. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi X, Wang X and Hua Y: LncRNA GACAT1
promotes gastric cancer cell growth, invasion and migration by
regulating MiR-149-mediated of ZBTB2 and SP1. J Cancer.
9:3715–3722. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang HM, Lu JH, Chen WY and Gu AQ:
Upregulated lncRNA-UCA1 contributes to progression of lung cancer
and is closely related to clinical diagnosis as a predictive
biomarker in plasma. Int J Clin Exp Med. 8:11824–11830.
2015.PubMed/NCBI
|
|
20
|
Wang YH, Ji J, Wang BC, Chen H, Yang ZH,
Wang K, Luo CL, Zhang WW, Wang FB and Zhang XL: Tumor-derived
exosomal long noncoding RNAs as promising diagnostic biomarkers for
prostate cancer. Cell Physiol Biochem. 46:532–545. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Elsayed ET, Salem PE, Darwish AM and Fayed
HM: Plasma long non-coding RNA HOTAIR as a potential biomarker for
gastric cancer. Int J Biol Markers. Apr 1–2018.(Epub ahead of
print). doi: 10.1177/1724600818760244. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu M, Wang Y, Liu X, Wen X, Liang C and
Tu J: LncRNAs act as prognostic biomarkers in gastric cancer: A
systematic review and meta-analysis. Front Lab Med. 1:59–68. 2017.
View Article : Google Scholar
|
|
23
|
Iranpour M, Soudyab M, Geranpayeh L,
Mirfakhraie R, Azargashb E, Movafagh A and Ghafouri-Fard S:
Expression analysis of four long noncoding RNAs in breast cancer.
Tumour Biol. 37:2933–2940. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao W, Luo J and Jiao S: Comprehensive
characterization of cancer subtype associated long non-coding RNAs
and their clinical implications. Sci Rep. 4:65912014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Lian Y, Yan C, Cai Z, Ding J, Ma Z,
Peng P and Wang K: Long non-coding RNA FOXP4-AS1 is an unfavourable
prognostic factor and regulates proliferation and apoptosis in
colorectal cancer. Cell Prolif. 50:2017. View Article : Google Scholar
|
|
26
|
He W, Zhong G, Jiang N, Wang B, Fan X,
Chen C, Chen X, Huang J and Lin T: Long noncoding RNA BLACAT2
promotes bladder cancer-associated lymphangiogenesis and lymphatic
metastasis. J Clin Invest. 128:861–875. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang ZT, Li Z, Wang XG, Tan T, Yi F, Zhu
H, Zhao JP and Zhou XF: Overexpression of long non-coding RNA ZXF2
promotes lung adenocarcinoma progression through c-Myc pathway.
Cell Physiol Biochem. 35:2360–2370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thai P, Statt S, Chen CH, Liang E,
Campbell C and Wu R: Characterization of a novel long noncoding
RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer
cell lines. Am J Respir Cell Mol Biol. 49:204–211. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Beckedorff FC, Ayupe AC, Crocci-Souza R,
Amaral MS, Nakaya HI, Soltys DT, Menck CF, Reis EM and
Verjovski-Almeida S: The intronic long noncoding RNA ANRASSF1
recruits PRC2 to the RASSF1A promoter, reducing the expression of
RASSF1A and increasing cell proliferation. PLoS Genet.
9:e10037052013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Szász AM, Lánczky A, Nagy Á, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cooper MG: The development and causes of
cancer. The Cell: A Molecular Approach. 2nd. NCBI Bookshelf;
Sunderland, MA: 2000
|
|
37
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yao XM, Tang JH, Zhu H and Jing Y: High
expression of LncRNA CASC15 is a risk factor for gastric cancer
prognosis and promote the proliferation of gastric cancer. Eur Rev
Med Pharmacol Sci. 21:5661–5667. 2017.PubMed/NCBI
|
|
39
|
Uzan VR, Lengert Av, Boldrini É, Penna V,
Scapulatempo-Neto C, Scrideli CA, Filho AP, Cavalcante CE, de
Oliveira CZ, Lopes LF and Vidal DO: High expression of HULC is
associated with poor prognosis in osteosarcoma patients. PLoS One.
11:e01567742016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dorak MT and Karpuzoglu E: Gender
differences in cancer susceptibility: An inadequately addressed
issue. Front Genet. 3:2682012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Deng JY and Liang H: Clinical significance
of lymph node metastasis in gastric cancer. World J Gastroenterol.
20:3967–3975. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cho JK, Hyun SH, Choi N, Kim MJ, Padera
TP, Choi JY and Jeong HS: Significance of lymph node metastasis in
cancer dissemination of head and neck cancer. Transl Oncol.
8:119–125. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cuschieri A, Joypaul V, Fayers P, Cook P,
Fielding J and Craven J: Postoperative morbidity and mortality
after D1 and D2 resections for gastric cancer: Preliminary results
of the MRC randomised controlled surgical trial. Lancet.
347:995–999. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shitara K, Yatabe Y, Matsuo K, Sugano M,
Kondo C, Takahari D, Ura T, Tajika M, Ito S and Muro K: Prognosis
of patients with advanced gastric cancer by HER2 status and
trastuzumab treatment. Gastric Cancer. 16:261–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou Q, Hou CN, Yang HJ, He Z and Zuo MZ:
Distinct expression and prognostic value of members of the
epidermal growth factor receptor family in ovarian cancer. Cancer
Manag Res. 10:6937–6948. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gao F, Zhang X, Whang S and Zheng C:
Prognostic impact of plasma ORM2 levels in patients with stage II
colorectal cancer. Ann Clin Lab Sci. 44:388–393. 2014.PubMed/NCBI
|
|
47
|
Li P, Zhang X, Wang H, Wang L, Liu T, Du
L, Yang Y and Wang C: MALAT1 is associated with poor response to
oxaliplatin-based chemotherapy in colorectal cancer patients and
promotes chemoresistance through EZH2. Mol Cancer Ther. 16:739–751.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Du L, Duan W, Jiang X, Zhao L, Li J, Wang
R, Yan S, Xie Y, Yan K, Wang Q, et al: Cell-free lncRNA expression
signatures in urine serve as novel non-invasive biomarkers for
diagnosis and recurrence prediction of bladder cancer. J Cell Mol
Med. 22:2838–2845. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li C, Li W, Zhang Y, Zhang X, Liu T, Zhang
Y, Yang Y, Wang L, Pan H, Ji J and Wang C: Increased expression of
antisense lncRNA SPINT1-AS1 predicts a poor prognosis in colorectal
cancer and is negatively correlated with its sense transcript. Onco
Targets Ther. 11:3969–3978. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Terai G, Iwakiri J, Kameda T, Hamada M and
Asai K: Comprehensive prediction of lncRNA-RNA interactions in
human transcriptome. BMC Genomics. 17 (Suppl 1):S122016. View Article : Google Scholar
|
|
51
|
Lei F, Zhang H and Xie X: Comprehensive
analysis of an lncRNA-miRNA-mRNA competing endogenous RNA network
in pulpitis. PeerJ. 7:e71352019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tang XJ, Wang W and Hann SS: Interactions
among lncRNAs, miRNAs and mRNA in colorectal cancer. Biochimie.
163:58–72. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Thomas LR, Wang Q, Grieb BC, Phan J,
Foshage AM, Sun Q, Olejniczak ET, Clark T, Dey S, Lorey S, et al:
Interaction with WDR5 promotes target gene recognition and
tumorigenesis by MYC. Mol Cell. 440–452. 2015. View Article : Google Scholar : PubMed/NCBI
|
